EFSCE
MACK

Enterprise Financial Services Corp (EFSC)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16
Closed -$1K – 1085
2016
Q1 		$1K Hold
16
– – ﹤0.01% 1031
2015
Q4 		$1K Hold
16
– – ﹤0.01% 1083
2015
Q3 		$1K Hold
16
– – ﹤0.01% 1066
2015
Q2 		$2K Hold
16
– – ﹤0.01% 961
2015
Q1 		$2K Hold
16
– – ﹤0.01% 1076
2014
Q4 		$1K Buy
+16
New +$1.17K ﹤0.01% 1257

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s MACK Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2016, closing a stake of 16 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in MACK in Q4 2014 and held it in 6 quarters. The position peaked at $2K in Q2 2015. 140 funds tracked by Wall St. Rank hold MACK as of Q2 2016.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 16 Merrimack Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2014 and held it in 6 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Merrimack Pharmaceuticals, Inc. position peaked at $2K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.